Novaccess Global INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
NovAccess Global Inc. has entered into a securities purchase agreement for a $65,000 loan, issuing a promissory note and warrants to AJB Capital Investments, LLC, to fund debt repayment, operations, and the filing of its June 30, 2024, quarterly report.
OTC.Pink
NovAccess Global Inc. reports the resignation of its CFO, Neil J. Laird, effective July 26, 2024, and the appointment of CEO Dwain K. Irvin as interim CFO.
OTC.Pink
NovAccess Global Inc. has entered into an interest-free convertible loan agreement with its chairman, John A. Cassarini, for $9,000 to address short-term cash needs.
OTC.Pink
NovAccess Global Inc. has entered into a securities purchase agreement for a $117,000 loan and acquired an 18.6% stake in Fendix Media Limited, a UK healthcare marketing firm.
OTC.Pink
NovAccess Global Inc. has entered into a securities purchase agreement for a $26,500 loan and acquired a new intellectual property license to enhance its immunotherapy platform.
OTC.Pink
NovAccess Global Inc. has entered into a securities purchase agreement for a $100,000 loan to support its working capital needs.
OTC.Pink
NovAccess Global has defaulted on a $55,000 loan, with the lender demanding immediate repayment of $86,000, while a crucial $10.68 million funding deal is delayed.
OTC.Pink
NovAccess Global is in default on convertible promissory notes and lacks the funds to repay its debts, facing potential conversion of debt to equity at a significant discount.